FiroozNAlbertDAWallaceDJIshimoriMBerelDWeismanMHHigh-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus2011; 20: 588–597.
2.
BarnesEVNarainSNaranjoAHigh sensitivity C-reactive protein in systemic lupus erythematosus: Relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus2005; 14: 576–582.
3.
Amezcua-GuerraLMSpringallRArrieta-AlvaradoAAC-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus. Clin Lab2011, 57:607–6132011.
4.
LeeSSSinghSLinkKPetriMHigh-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. Semin Arthritis Rheum2008; 38: 41–54.
5.
SpronkPEter BorgEJKallenbergCGPatients with systemic lupus erythematosus and Jaccoud’s arthropathy: A clinical subset with an increased C reactive protein response?Ann Rheum Dis1992; 51: 358–361.
6.
WilliamsRC JrHarmonMEBurlingameRDu ClosTWStudies of serum C-reactive protein in systemic lupus erythematosus. JRheumatol2005; 32: 454–461.
7.
Amezcua-GuerraLMMárquez-VelascoRBojalilRErosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies. Inflamm Res2008; 57: 555–557.
8.
WindgassenEBFuntowiczLLunsfordTNHarrisLAMulvaghSLC-reactive protein and high-sensitivity C-reactive protein: Anupdate for clinicians. Postgrad Med2011; 123: 114–119.
9.
Castillo-MartínezDAmezcua-GuerraLMBojalilRNeutropenia and the risk of infections in ambulatory patients with systemic lupus erythematosus: A three-year prospective study cohort. Lupus2011; 20: 998–1000.